Jing L. Marantz - 07 Dec 2021 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Director
Signature
/s/ Jing L. Marantz
Issuer symbol
ARCT
Transactions as of
07 Dec 2021
Net transactions value
$0
Form type
4
Filing time
09 Dec 2021, 19:13:02 UTC
Previous filing
02 Jul 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Stock option (right to buy) Award $0 +20,000 $0.000000 20,000 07 Dec 2021 Common Stock 20,000 $38.54 Direct F1
transaction ARCT Stock option (right to buy) Award $0 +6,699 $0.000000 6,699 07 Dec 2021 Common Stock 6,699 $38.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors (the "Board").
F2 Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board, representing an estimated six months of service.